Mumbai: Maharashtra Chief Minister Eknath Shinde and Deputy Chief Minister Devendra Fadnavis inaugurated Phase 2A of Mumbai Metro Line 3 on Friday, marking a significant milestone in the city’s ...

In a big leap for Mumbai’s public transport, Metro Line 3's second phase—connecting Bandra-Kurla Complex (BKC) to Acharya Atre Chowk in Worli—officially began operations on Saturday ...

Wuthering Waves is geared up for the first anniversary with the Version 2.3 Phase 2. It will launch on May 22, 2025. The update will introduce Ciaccona, a 5-star Aero Resonator and some fan ...

An official post on X (formerly Twitter) by Mumbai Metro Line 3 shared important details about this newly operational phase. A total of six stations have been made available to passengers on this ...

GSK has shared the data behind its phase 3 liver disease win, revealing patients on linerixibat reported reductions in itching that began after two weeks and persisted through the 24-week primary ...

no evidence of lymphopenia or CD4 cell count reduction was observed with the islatravir component. Only 2% to 3% of patients discontinued due to adverse events, indicating good tolerability.

The Edmonton Oilers have Stuart Skinner in the starter’s net at today’s skate. Said the Oilers: “Stuart Skinner will make the start for the Oilers against the Golden Knights in Game 3 at ...

A drug billed by Sanofi as a successor to its blockbuster inflammation and immunology blockbuster Dupixent is being prepared for phase 3 trials in asthma – even though it missed the mark in a ...

Biotech company Zealand Pharma A/S, an innovator in peptide-based medicines, announced the positive topline results from its phase 3 trial of glepaglutide on Friday. A total of 106 patients with ...

Bayer has advanced its small-molecule drug BAY 2927088 into phase 3 for non-small cell lung cancer ... which will look at the drug’s potential as a first-line treatment for this type of lung ...

Buoyed by new results from a phase 1b/2a trial, Roche has said it plans to start a phase 3 programme for an Alzheimer's disease candidate from its Brainshuttle programme, a technology designed to ...

Bayer has added another phase 3 trial into its registration programme for oral Factor XIa inhibitor asundexian, signalling growing confidence in a drug that generated mixed results in phase 2.